PatchAi Startup has Arrived in the Market to Support Patients and Clinical Research
PatchAi - a startup that offers, thanks to Artificial Intelligence and Machine Learning, an empathic virtual assistant to patients participating in clinical trials - announced that it has closed two rounds of fundraising for about 900 thousand euros in 2019. The startup's service provision has been active since December 2019 and among the first PatchAi® clients is Novartis Italia, thus confirming its position as one of the fastest rising startups in the health sector. 
CT scanners with intelligent user guidance, AI-based software assistants for MRI and a lab system that revolutionizes workflows: Siemens Healthineers is showcasing its products and solutions according to the motto "Shaping the Future of Healthcare" at this year's Arab Health in Dubai, UAE, focusing on digital transformation of imaging and laboratory testing while improving patient experience. 
Brainlab, the digital medical technology company, announced the recent acquisition of VisionTree Software, Inc., a San Diego based company that develops cloud-based, patient-centric data collection and health management solutions. The acquisition re-emphasizes the Brainlab commitment to 
Today, the U.S. Food and Drug Administration is issuing a safety communication informing health care providers, facilities and patients about cybersecurity vulnerabilities identified for certain GE Healthcare Clinical Information Central Stations and Telemetry Servers. These devices are primarily used in health care facilities for 
Bolton NHS Foundation Trust is now live with Sunrise™ Acute Care, following one of the most extensive initial deployments for the Allscripts electronic patient record in the UK.
Bayer and Exscientia Ltd., a UK-based Artificial Intelligence (AI)-driven drug discovery company, have entered into a three-year, multi-target collaboration. The partners will work on early research projects combining Exscientia's proprietary AI drug discovery platform and drug design know-how with Bayer's data and drug discovery capabilities.